The cycle of genome-directed medicine
-
* Corresponding author: Stephen W Scherer swscherer@sickkids.ca
1 The Centre for Applied Genomics, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada
2 Research Institute Program in Genetics and Genome Biology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada
3 Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada
4 Division of Clinical & Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada
5 Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada
6 Department of Molecular Genetics, The University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada
7 Department of Pediatrics, The University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada
8 Department of Medical Biophysics, The University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada
Genome Medicine 2009, 1:16 doi:10.1186/gm16
Published: 2 February 2009Abstract
The genome era in medicine is upon us. Questions that arise from patient and family care are a watershed for research and technology, which in turn fuel the cycle of opportunity for impact through delivery of health services, which feeds back to families. Medical infrastructure needs to adapt to the dramatic pace of technology development in the wake of the Human Genome Project, in order for genome data to be delivered as information and applied as knowledge to benefit health.